Literature DB >> 23072059

[TaqMan fluorescent probe-based real-time PCR assay for detection of varicella-zoster virus].

Szymon Kierat1, Katarzyna Leś, Maciej Przybylski, Tomasz Dzieciatkowski, Grazyna Młynarczyk.   

Abstract

INTRODUCTION: Varicella-zoster virus (HHV-3) is spread by the respiratory route and disseminates to lymph nodes and then via lymph back to the skin, resulting with the rash of chickenpox. Like other alpha-herpesviruses, HHV-3 infects the neurons of the dorsal root ganglia, where it causes lifelong latency. Virus reactivation causes episode of herpes zoster (shingles). During severe HHV-3 infections molecular methods, such as real-time PCR (qPCR) assay, are recognized as a method-of-choice for detecting viral DNA in clinical specimens. The aim of this study was to develop the qPCR assay for detection and quantification of varicella-zoster virus DNA in different clinical samples, using specific primers targeting a HHV-3 DNA ORF62 gene and a fluorescent TaqMan probe.
METHODS: The analytical sensitivity of assay was tested using serial dilutions of viral DNA in range between 100 and 3 125 000 copies/ml. Limit of detection (LOD) was calculated using probit analysis, and was determined as 750 copies/ml. In further studies 18 clinical samples (sera, whole blood, skin swabs), taken from a small group of 5 children with symptoms of chickenpox were tested for the presence of varicella-zoster virus DNA, using LightCycler 2.0 system.
RESULTS: Described in-house qPCR method detected viral DNA in all examined specimens. Detected viral load was between 5750 copies/ml for sera samples and 27 300 000 copies/ ml for skin swabs, respectively.
CONCLUSIONS: The results of this work showed that developed real-time PCR assay based on TaqMan probe was very reliable and valuable for detection and quantification of varicella-zoster virus DNA in different clinical samples. The high level of sensitivity, specificity, accuracy, and rapidity provided by the developed method are favorable for its use for the detection of HHV-3 DNA in laboratory practice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23072059

Source DB:  PubMed          Journal:  Med Dosw Mikrobiol        ISSN: 0025-8601


  5 in total

1.  Search for Viral Infections in Cerebrospinal Fluid From Patients With Autoimmune Encephalitis.

Authors:  Karol Perlejewski; Agnieszka Pawełczyk; Iwona Bukowska-Ośko; Małgorzata Rydzanicz; Tomasz Dzieciątkowski; Marcin Paciorek; Michał Makowiecki; Kamila Caraballo Cortés; Marta Grochowska; Marek Radkowski; Tomasz Laskus
Journal:  Open Forum Infect Dis       Date:  2020-10-07       Impact factor: 3.835

2.  Dysregulated microRNA expression in serum of non-vaccinated children with varicella.

Authors:  Yuhua Qi; Zheng Zhu; Zhiyang Shi; Yiyue Ge; Kangchen Zhao; Minghao Zhou; Lunbiao Cui
Journal:  Viruses       Date:  2014-04-22       Impact factor: 5.048

3.  Viral etiologies in adult patients with encephalitis in Poland: A prospective single center study.

Authors:  Marta Popiel; Karol Perlejewski; Agnieszka Bednarska; Tomasz Dzieciątkowski; Marcin Paciorek; Dariusz Lipowski; Monika Jabłonowska; Hanna Czeszko-Paprocka; Iwona Bukowska-Ośko; Kamila Caraballo Cortes; Agnieszka Pawełczyk; Maria Fic; Andrzej Horban; Marek Radkowski; Tomasz Laskus
Journal:  PLoS One       Date:  2017-06-01       Impact factor: 3.240

4.  Search for viral agents in cerebrospinal fluid in patients with multiple sclerosis using real-time PCR and metagenomics.

Authors:  Karol Perlejewski; Iwona Bukowska-Ośko; Małgorzata Rydzanicz; Tomasz Dzieciątkowski; Beata Zakrzewska-Pniewska; Aleksandra Podlecka-Piętowska; Agata Filipiak; Krzysztof Barć; Kamila Caraballo Cortés; Agnieszka Pawełczyk; Marek Radkowski; Tomasz Laskus
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

5.  Next-generation sequencing in the diagnosis of viral encephalitis: sensitivity and clinical limitations.

Authors:  Karol Perlejewski; Iwona Bukowska-Ośko; Małgorzata Rydzanicz; Agnieszka Pawełczyk; Kamila Caraballo Cortѐs; Sylwia Osuch; Marcin Paciorek; Tomasz Dzieciątkowski; Marek Radkowski; Tomasz Laskus
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.